dipyridamole and pemetrexed

dipyridamole has been researched along with pemetrexed in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	4 (57.14)	29.6817
2010's	1 (14.29)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Calvert, AH; Curtin, NJ; Marshman, E; Newell, DR; Smith, PG	1
Curtin, NJ; Marshman, E; Newell, DR; Smith, PG	1
Barlow, HC; Calvert, AH; Curtin, NJ; Golding, BT; Griffin, RJ; Newell, DR; Smith, PG; Thomas, HD	1
Curigliano, G; Danesi, R; De Braud, F; De Cobelli, O; Del Tacca, M; Giovannetti, E; Mey, V; Nannizzi, S; Pece, S; Verweij, F	1
Barlow, H; Barton, M; Curtin, NJ; Golding, BT; Griffin, RJ; Lin, MJ; Newell, DR; Northen, JS; Saravanan, K; Thomas, HD; Wang, LZ	1

Reviews

1 review(s) available for dipyridamole and pemetrexed

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for dipyridamole and pemetrexed

Article	Year
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients. British journal of cancer, 2006, Aug-07, Volume: 95, Issue:3 Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Deoxycytidine Kinase; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Equilibrative Nucleoside Transporter 1; Excitatory Amino Acid Antagonists; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Phosphoribosylglycinamide Formyltransferase; Phosphorylation; Proto-Oncogene Proteins c-akt; S Phase; Thioinosine; Thymidylate Synthase; Treatment Outcome; Urinary Bladder Neoplasms	2006

Article

Year

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.

British journal of cancer, 2006, Aug-07, Volume: 95, Issue:3

Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Deoxycytidine Kinase; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Equilibrative Nucleoside Transporter 1; Excitatory Amino Acid Antagonists; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Male; Middle Aged; Neoplasm Staging; Pemetrexed; Phosphoribosylglycinamide Formyltransferase; Phosphorylation; Proto-Oncogene Proteins c-akt; S Phase; Thioinosine; Thymidylate Synthase; Treatment Outcome; Urinary Bladder Neoplasms

2006

Other Studies

5 other study(ies) available for dipyridamole and pemetrexed

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines. Seminars in oncology, 1999, Volume: 26, Issue:2 Suppl 6 Topics: Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cell Division; Dipyridamole; Enzyme Inhibitors; Folic Acid Antagonists; Glutamates; Guanine; Humans; Hypoxanthine; Lung Neoplasms; Pemetrexed; Phosphodiesterase Inhibitors; Thymidine; Thymidylate Synthase; Tumor Cells, Cultured	1999
Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport. British journal of cancer, 2000, Volume: 82, Issue:4 Topics: Biological Transport; Dipyridamole; Drug Synergism; Enzyme Inhibitors; Glutamates; Guanine; Humans; Pemetrexed; Thymidine; Thymidylate Synthase; Tumor Cells, Cultured	2000
In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:7 Topics: Animals; Carrier Proteins; Cell Division; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Female; Folic Acid Antagonists; Glutamates; Guanine; Humans; Hypoxanthine; Liver; Membrane Proteins; Mice; Mice, Inbred BALB C; Nucleoside Transport Proteins; Orosomucoid; Pemetrexed; Tetrahydrofolates; Thymidine; Time Factors; Tritium; Tumor Cells, Cultured	2001
Preclinical evaluation of a novel pyrimidopyrimidine for the prevention of nucleoside and nucleobase reversal of antifolate cytotoxicity. Molecular cancer therapeutics, 2009, Volume: 8, Issue:7 Topics: Animals; Antimetabolites, Antineoplastic; Cell Proliferation; Dipyridamole; Drug Synergism; Female; Folic Acid Antagonists; Glutamates; Guanine; Humans; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nucleosides; Orosomucoid; Pemetrexed; Phosphorylation; Prodrugs; Thymidine; Thymidylate Synthase; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2009